TAYSHA GENE THERAPIES INC (TSHA)
US8776191061 - Common Stock
TAYSHA GENE THERAPIES INC
NASDAQ:TSHA (11/12/2024, 8:00:01 PM)
After market: 2.4499 +0.06 (+2.51%)2.39
+0.76 (+46.63%)
Company Profile
Taysha Gene Therapies, Inc.is a patient-centric, clinical-stage gene therapy company, which engages in the development and commercialization of adeno-associated viruses (AAV) based gene therapies for the treatment of monogenic diseases of the central nervous system. The company is headquartered in Dallas, Texas and currently employs 52 full-time employees. The company went IPO on 2020-09-24. The Company’s lead clinical program, TSHA-102, is in development for the treatment of Rett syndrome, a rare neurodevelopmental disorder. The firm is evaluating TSHA-102 in the REVEALPhase I/II adolescent and adult clinical trial, which is a first-in-human, open-label, randomized, dose escalation and dose-expansion, multicenter study evaluating the safety and preliminary efficacy of TSHA-102 in female patients aged 12-years and older with Rett syndrome. The company has acquired a worldwide right to a clinical-stage, intrathecally dosed AAV9 gene therapy program, TSHA-120, for the treatment of giant axonal neuropathy (GAN). The company received orphan drug designation from the European Commission for TSHA-120 for the treatment of GAN.
Company Info
TAYSHA GENE THERAPIES INC
3000 Pegasus Park Drive, Suite 1430
Dallas TEXAS 75247
P: 12146120000
CEO: RA Session
Employees: 52
Website: https://tayshagtx.com/
TSHA News
13 hours ago - ChartmillHere are the top movers in Tuesday's session, showcasing the stocks with significant price changes.Stay up-to-date with the latest market trends one hour before the close of the markets on Tuesday. Explore the top gainers and losers during today's session in our detailed report.
15 hours ago - ChartmillLet's take a look at the stocks that are in motion in today's session.Let's have a look at the top gainers and losers in the middle of the day of today's session.
17 hours ago - ChartmillWhich stocks are gapping on Tuesday?The market is filled with gapping stocks in Tuesday's session. Let's discover which stocks are showing gap-ups and gap-downs.
19 hours ago - ChartmillWhat's going on in today's pre-market sessionThe US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
a day ago - ChartmillGet insights into the top gainers and losers of Monday's after-hours session.As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
12 days ago - Taysha Gene Therapies, Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)DALLAS, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company...
TSHA Twits
Here you can normally see the latest stock twits on TSHA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
